Mersana Therapeutics Inc.(MRSN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

MRSN Mersana Therapeutics Inc.

盘前交易 05-17 05:34:56 EDT

2.58

+0.01

+0.39%

最高2.63	最低2.46	成交量127.85万
今开2.57	昨收2.57	日振幅6.61%
总市值3.16亿	流通市值1.69亿	总股本1.22亿
成交额327.61万	换手率1.96%	流通股本6,536万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"MRSN","market":"US","secType":"STK","nameCN":"Mersana Therapeutics Inc.","latestPrice":2.58,"timestamp":1715889600000,"preClose":2.57,"halted":0,"volume":1278518,"delay":0,"floatShares":65364099,"shares":122361236,"eps":-1.130444,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.01,"latestTime":"05-17 05:34:56 EDT","open":2.57,"high":2.63,"low":2.46,"amount":3276136.2756193997,"amplitude":0.066148,"askPrice":2.84,"askSize":100,"bidPrice":2.36,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.130444,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1715952600000},"adr":0,"listingDate":1498622400000,"adjPreClose":2.58,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":2.58,"preClose":2.58,"latestTime":"19:06 EDT","volume":42244,"amount":108987.315,"timestamp":1715900778456},"volumeRatio":0.39813329555091304},"requestUrl":"/m/hq/s/MRSN/","defaultTab":"news","newsList":[{"id":"2434877043","title":"Mersana Therapeutics, Inc.盘中异动 股价大跌5.25%报3.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2434877043","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2434877043?lang=zh_cn&edition=full","pubTime":"2024-05-09 03:06","pubTimestamp":1715195213,"startTime":"0","endTime":"0","summary":"北京时间2024年05月09日03时06分，Mersana Therapeutics, Inc.股票出现波动，股价大幅下挫5.25%。Mersana Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Mersana Therapeutics, Inc.公司简介：梅莎娜制药有限公司是一家临床阶段的生物制药公司，利用其差异化和专有的 ADC 平台来开发具有更高耐受性和更多机会为患者带来有意义的临床益处的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050903065387e86808&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024050903065387e86808&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2433491787","title":"Mersana Therapeutics Inc   预计每股亏损18美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2433491787","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2433491787?lang=zh_cn&edition=full","pubTime":"2024-05-08 00:30","pubTimestamp":1715099443,"startTime":"0","endTime":"0","summary":"   * Mersana Therapeutics Inc    将于5月9日公布截至2024年3月31日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，8位分析师的平均预期显示，这家总部位于马萨诸塞州剑桥市的公司的营收预计将从去年同期的780万美元增长8.9%，达到850万美元。* LSEG 分析师对 Mersana Therapeutics Inc 的平均预期是每股亏损 18 美分。* 华尔街对 Mersana Therapeutics Inc 的 12 个月目标价中位数为 7.00 美元，高于其上次收盘价 3.50 美元。5月7日 - 上一季度业绩。除非另有说明，所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432290686","title":"Mersana Therapeutics Inc   预计每股亏损18美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2432290686","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2432290686?lang=zh_cn&edition=full","pubTime":"2024-05-03 22:18","pubTimestamp":1714745920,"startTime":"0","endTime":"0","summary":"   * Mersana Therapeutics Inc    将于5月9日公布截至2024年3月31日的财报，预计该公司的季度收入将有所增长。* 根据LSEG的数据，8位分析师的平均预期显示，这家总部位于马萨诸塞州剑桥市的公司的营收预计将从去年同期的780万美元增长8.9%，达到850万美元。* LSEG 分析师对 Mersana Therapeutics Inc 的平均预期是每股亏损 18 美分。* 华尔街对 Mersana Therapeutics Inc 的 12 个月目标价中位数为 7.00 美元，高于其上次收盘价 3.36 美元。5月3日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2432908531","title":"Mersana Therapeutics, Inc.盘中异动 急速拉升6.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2432908531","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432908531?lang=zh_cn&edition=full","pubTime":"2024-05-03 21:32","pubTimestamp":1714743167,"startTime":"0","endTime":"0","summary":"北京时间2024年05月03日21时32分，Mersana Therapeutics, Inc.股票出现异动，股价大幅上涨6.25%。Mersana Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。Mersana Therapeutics, Inc.公司简介：梅莎娜制药有限公司是一家临床阶段的生物制药公司，利用其差异化和专有的 ADC 平台来开发具有更高耐受性和更多机会为患者带来有意义的临床益处的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032132477a57fb2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202405032132477a57fb2f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432128570","title":"Mersana Therapeutics, Inc.盘中异动 急速拉升5.05%报3.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432128570","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432128570?lang=zh_cn&edition=full","pubTime":"2024-05-01 21:37","pubTimestamp":1714570679,"startTime":"0","endTime":"0","summary":"北京时间2024年05月01日21时37分，Mersana Therapeutics, Inc.股票出现异动，股价大幅上涨5.05%。Mersana Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。Mersana Therapeutics, Inc.公司简介：梅莎娜制药有限公司是一家临床阶段的生物制药公司，利用其差异化和专有的 ADC 平台来开发具有更高耐受性和更多机会为患者带来有意义的临床益处的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240501213759861ea863&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240501213759861ea863&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2431861754","title":"Mersana Therapeutics, Inc.盘中异动 快速上涨5.10%报3.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431861754","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2431861754?lang=zh_cn&edition=full","pubTime":"2024-04-29 22:00","pubTimestamp":1714399250,"startTime":"0","endTime":"0","summary":"北京时间2024年04月29日22时00分，Mersana Therapeutics, Inc.股票出现异动，股价大幅上涨5.10%。Mersana Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.91%。Mersana Therapeutics, Inc.公司简介：梅莎娜制药有限公司是一家临床阶段的生物制药公司，利用其差异化和专有的 ADC 平台来开发具有更高耐受性和更多机会为患者带来有意义的临床益处的靶向药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042922005087e84c12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042922005087e84c12&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429123391","title":"Mersana Therapeutics, Inc.盘中异动 股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429123391","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429123391?lang=zh_cn&edition=full","pubTime":"2024-04-24 00:06","pubTimestamp":1713888367,"startTime":"0","endTime":"0","summary":"北京时间2024年04月24日00时06分，Mersana Therapeutics, Inc.股票出现异动，股价大幅拉升5.08%。Mersana Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.40%。Mersana Therapeutics, Inc.公司简介：梅莎娜制药公司是一家临床阶段的生物制药公司，利用其差异化和专有的 ADC 平台开发具有更高耐受性和更多机会的靶向药物，为患者带来有意义的临床益处。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240424000607861e838a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240424000607861e838a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429765449","title":"Mersana Therapeutics, Inc.盘中异动 股价大跌5.23%报3.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2429765449","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429765449?lang=zh_cn&edition=full","pubTime":"2024-04-22 23:57","pubTimestamp":1713801422,"startTime":"0","endTime":"0","summary":"北京时间2024年04月22日23时57分，Mersana Therapeutics, Inc.股票出现波动，股价急速下挫5.23%。Mersana Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.22%。Mersana Therapeutics, Inc.公司简介：梅莎娜制药公司是一家临床阶段的生物制药公司，利用其差异化和专有的 ADC 平台开发具有更高耐受性和更多机会的靶向药物，为患者带来有意义的临床益处。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240422235702792260a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240422235702792260a5&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428454604","title":"Mersana Therapeutics, Inc.盘中异动 下午盘股价大跌5.11%报3.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428454604","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428454604?lang=zh_cn&edition=full","pubTime":"2024-04-19 03:22","pubTimestamp":1713468131,"startTime":"0","endTime":"0","summary":"北京时间2024年04月19日03时22分，Mersana Therapeutics, Inc.股票出现波动，股价快速下跌5.11%。Mersana Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.65%。Mersana Therapeutics, Inc.公司简介：梅莎娜制药公司是一家临床阶段的生物制药公司，利用其差异化和专有的 ADC 平台开发具有更高耐受性和更多机会的靶向药物，为患者带来有意义的临床益处。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419032212861e721f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240419032212861e721f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426359190","title":"Mersana Therapeutics, Inc.盘中异动 大幅下跌5.17%报3.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2426359190","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426359190?lang=zh_cn&edition=full","pubTime":"2024-04-09 21:51","pubTimestamp":1712670675,"startTime":"0","endTime":"0","summary":"北京时间2024年04月09日21时51分，Mersana Therapeutics, Inc.股票出现波动，股价急速下跌5.17%。Mersana Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.05%。Mersana Therapeutics, Inc.公司简介：梅莎娜制药公司是一家临床阶段的生物制药公司，利用其差异化和专有的 ADC 平台开发具有更高耐受性和更多机会的靶向药物，为患者带来有意义的临床益处。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409215115861e43bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240409215115861e43bc&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424044332","title":"Mersana Therapeutics, Inc.盘中异动 早盘大幅下挫5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424044332","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424044332?lang=zh_cn&edition=full","pubTime":"2024-04-02 22:21","pubTimestamp":1712067674,"startTime":"0","endTime":"0","summary":"北京时间2024年04月02日22时21分，Mersana Therapeutics, Inc.股票出现波动，股价大幅下挫5.19%。Mersana Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.80%。Mersana Therapeutics, Inc.公司简介：梅莎娜制药公司是一家临床阶段的生物制药公司，利用其差异化和专有的 ADC 平台开发具有更高耐受性和更多机会的靶向药物，为患者带来有意义的临床益处。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402222115861e305b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402222115861e305b&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2422540181","title":"Mersana Therapeutics, Inc.盘中异动 临近午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2422540181","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2422540181?lang=zh_cn&edition=full","pubTime":"2024-03-25 23:55","pubTimestamp":1711382140,"startTime":"0","endTime":"0","summary":"北京时间2024年03月25日23时55分，Mersana Therapeutics, Inc.股票出现波动，股价急速下挫5.00%。Mersana Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.12%。Mersana Therapeutics, Inc.公司简介：梅莎娜制药公司是一家临床阶段的生物制药公司，利用其差异化和专有的 ADC 平台开发具有更高耐受性和更多机会的靶向药物，为患者带来有意义的临床益处。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240325235540791cb14c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240325235540791cb14c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2421507046","title":"Mersana Therapeutics, Inc.盘中异动 急速拉升5.17%报5.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2421507046","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2421507046?lang=zh_cn&edition=full","pubTime":"2024-03-21 21:41","pubTimestamp":1711028517,"startTime":"0","endTime":"0","summary":"北京时间2024年03月21日21时41分，Mersana Therapeutics, Inc.股票出现异动，股价大幅上涨5.17%。Mersana Therapeutics, Inc.公司简介：梅莎娜制药公司是一家临床阶段的生物制药公司，利用其差异化和专有的 ADC 平台开发具有更高耐受性和更多机会的靶向药物，为患者带来有意义的临床益处。消息层面，截至21时41分，Mersana Therapeutics, Inc.股票正面舆情新闻比例33.33%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032121415887e7ab85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024032121415887e7ab85&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420722257","title":"Mersana Therapeutics, Inc.盘中异动 临近午盘大幅跳水5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2420722257","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420722257?lang=zh_cn&edition=full","pubTime":"2024-03-20 23:32","pubTimestamp":1710948755,"startTime":"0","endTime":"0","summary":"北京时间2024年03月20日23时32分，Mersana Therapeutics, Inc.股票出现波动，股价大幅下跌5.04%。Mersana Therapeutics, Inc.公司简介：梅莎娜制药公司是一家临床阶段的生物制药公司，利用其差异化和专有的 ADC 平台开发具有更高耐受性和更多机会的靶向药物，为患者带来有意义的临床益处。消息层面，截至23时32分，Mersana Therapeutics, Inc.股票正面舆情新闻比例50%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403202332357a4dfd2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403202332357a4dfd2f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2420255290","title":"美国研究综述-美国大厦、莱纳尔、耐克","url":"https://stock-news.laohu8.com/highlight/detail?id=2420255290","media":"Reuters","top":-1,"share":"https://www.laohu8.com/m/news/2420255290?lang=zh_cn&edition=full","pubTime":"2024-03-19 15:17","pubTimestamp":1710832652,"startTime":"0","endTime":"0","summary":"    路透社3月19日 - 华尔街证券分析师周二调整了对美国塔、莱纳尔和耐克等几家美国上市公司的评级和目标价。* 耐克公司   ：Wedbush将目标价从131美元下调至115美元 * Zoom Video Communications   ：杰富瑞给予该公司 \"持有 \"评级，目标价为70美元 以下是路透社周二报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"gpt_icon":0},{"id":"2420472582","title":"Mersana Therapeutics, Inc.盘中异动 股价大跌8.73%报4.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2420472582","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2420472582?lang=zh_cn&edition=full","pubTime":"2024-03-18 21:31","pubTimestamp":1710768672,"startTime":"0","endTime":"0","summary":"北京时间2024年03月18日21时31分，Mersana Therapeutics, Inc.股票出现波动，股价急速下跌8.73%。Mersana Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。Mersana Therapeutics, Inc.公司简介：梅莎娜制药公司是一家临床阶段的生物制药公司，利用其差异化和专有的 ADC 平台开发具有更高耐受性和更多机会的靶向药物，为患者带来有意义的临床益处。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031821311287e79bf9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024031821311287e79bf9&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419398891","title":"Mersana Therapeutics, Inc.盘中异动 股价大跌5.05%报5.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419398891","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419398891?lang=zh_cn&edition=full","pubTime":"2024-03-14 22:17","pubTimestamp":1710425840,"startTime":"0","endTime":"0","summary":"北京时间2024年03月14日22时17分，Mersana Therapeutics, Inc.股票出现异动，股价大幅下跌5.05%。Mersana Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.61%。Mersana Therapeutics, Inc.公司简介：梅莎娜制药公司是一家临床阶段的生物制药公司，利用其差异化和专有的 ADC 平台开发具有更高耐受性和更多机会的靶向药物，为患者带来有意义的临床益处。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142217207a4cb829&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403142217207a4cb829&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2419136682","title":"Mersana Therapeutics, Inc.盘中异动 急速拉升5.14%报5.93美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2419136682","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2419136682?lang=zh_cn&edition=full","pubTime":"2024-03-13 21:40","pubTimestamp":1710337210,"startTime":"0","endTime":"0","summary":"北京时间2024年03月13日21时40分，Mersana Therapeutics, Inc.股票出现波动，股价急速上涨5.14%。Mersana Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.15%。Mersana Therapeutics, Inc.公司简介：梅莎娜制药公司是一家临床阶段的生物制药公司，利用其差异化和专有的 ADC 平台开发具有更高耐受性和更多机会的靶向药物，为患者带来有意义的临床益处。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403132140107a4c546d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202403132140107a4c546d&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2418769368","title":"Mersana Therapeutics, Inc.盘中异动 早盘急速上涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2418769368","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2418769368?lang=zh_cn&edition=full","pubTime":"2024-03-11 21:33","pubTimestamp":1710163986,"startTime":"0","endTime":"0","summary":"北京时间2024年03月11日21时33分，Mersana Therapeutics, Inc.股票出现异动，股价快速拉升5.10%。Mersana Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.44%。Mersana Therapeutics, Inc.公司简介：梅莎娜制药公司是一家临床阶段的生物制药公司，利用其差异化和专有的 ADC 平台开发具有更高耐受性和更多机会的靶向药物，为患者带来有意义的临床益处。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240311213307861dd122&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240311213307861dd122&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.mersana.com","stockEarnings":[{"period":"1week","weight":0.0467},{"period":"1month","weight":-0.3138},{"period":"3month","weight":-0.3211},{"period":"6month","weight":0.6645},{"period":"1year","weight":-0.6671},{"period":"ytd","weight":0.1121}],"compareEarnings":[{"period":"1week","weight":0.0164},{"period":"1month","weight":0.05},{"period":"3month","weight":0.0584},{"period":"6month","weight":0.1728},{"period":"1year","weight":0.2732},{"period":"ytd","weight":0.1123}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Mersana Therapeutics, Inc.于2002年2月以名称Nanopharma Corp.在特拉华州注册成立。2005年11月，他们更名为Mersana Therapeutics，Inc.。2012年，公司资本重组，并专注于ADC。该公司是一家临床阶段生物制药公司，专注于开发抗体药物共轭物（ADC），为严重未满足需求的癌症患者提供临床意义上的益处。他们利用在ADC领域20年的行业学习开发专有技术，使他们能够相对于现有的ADC治疗设计ADC来提高功效，安全性和耐受性。此外，他们还与武田制药有限公司（武田）建立了战略合作关系，在美国和加拿大境外获得了XMT-1522的权利。他们还与武田和默克KGaA建立了战略研究与开发合作伙伴关系，以便根据其合作伙伴基于其Dolaflexin平台选择的有限数量的目标，开发和商业化其他ADC产品候选人。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.019423},{"month":2,"riseRate":0.571429,"avgChangeRate":0.173916},{"month":3,"riseRate":0,"avgChangeRate":-0.165787},{"month":4,"riseRate":0.428571,"avgChangeRate":0.027646},{"month":5,"riseRate":0.428571,"avgChangeRate":0.286641},{"month":6,"riseRate":0.333333,"avgChangeRate":-0.068119},{"month":7,"riseRate":0.285714,"avgChangeRate":-0.182744},{"month":8,"riseRate":0.571429,"avgChangeRate":0.096541},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.137028},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.038493},{"month":11,"riseRate":0.571429,"avgChangeRate":0.214233},{"month":12,"riseRate":0.428571,"avgChangeRate":0.053714}],"exchange":"NASDAQ","name":"Mersana Therapeutics Inc.","nameEN":"Mersana Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mersana Therapeutics Inc.(MRSN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Mersana Therapeutics Inc.(MRSN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Mersana Therapeutics Inc.,MRSN,Mersana Therapeutics Inc.股票,Mersana Therapeutics Inc.股票老虎,Mersana Therapeutics Inc.股票老虎国际,Mersana Therapeutics Inc.行情,Mersana Therapeutics Inc.股票行情,Mersana Therapeutics Inc.股价,Mersana Therapeutics Inc.股市,Mersana Therapeutics Inc.股票价格,Mersana Therapeutics Inc.股票交易,Mersana Therapeutics Inc.股票购买,Mersana Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mersana Therapeutics Inc.(MRSN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Mersana Therapeutics Inc.(MRSN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}